{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34531939", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "20"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "08", "Day": "23"}], "Language": ["eng"], "ELocationID": ["6492346", "10.1155/2021/6492346"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2021", "PubDate": {"Year": "2021"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms.", "Pagination": {"StartPage": "6492346", "MedlinePgn": "6492346"}, "Abstract": {"AbstractText": ["Coumarins belong to the benzopyrone family commonly found in many medicinal plants. Natural coumarins demonstrated a wide spectrum of pharmacological activities, including anti-inflammatory, anticoagulant, anticancer, antibacterial, antimalarial, casein kinase-2 (CK2) inhibitory, antifungal, antiviral, Alzheimer's disease inhibition, neuroprotective, anticonvulsant, phytoalexins, ulcerogenic, and antihypertensive. There are very few studies on the bioavailability of coumarins; therefore, further investigations are necessitated to study the bioavailability of different coumarins which already showed good biological activities in previous studies. On the evidence of varied pharmacological properties, the present work presents an overall review of the derivation, availability, and biological capacities of coumarins with further consideration of the essential mode of their therapeutic actions. In conclusion, a wide variety of coumarins are available, and their pharmacological activities are of current interest thanks to their synthetic accessibility and riches in medicinal plants. Coumarins perform the valuable function as therapeutic agents in a range of medical fields."], "CopyrightInformation": "Copyright \u00a9 2021 Javad Sharifi-Rad et al."}, "AuthorList": [{"Identifier": ["0000-0002-7301-8151"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Sharifi-Rad", "ForeName": "Javad", "Initials": "J"}, {"Identifier": ["0000-0002-5934-5201"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, University of Porto, Alameda Prof. Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal."}, {"Identifier": [], "Affiliation": "Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal."}, {"Identifier": [], "Affiliation": "Institute of Research and Advanced Training in Health Sciences and Technologies (CESPU), Rua Central de Gandra, 1317, 4585-116, Gandra, PRD, Portugal."}], "LastName": "Cruz-Martins", "ForeName": "Nat\u00e1lia", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto Murciano de Investigaci\u00f3n Biosanitaria (IMIB-Arrixaca-UMU), Cl\u00ednica Odontol\u00f3gica Universitaria Hospital Morales Meseguer, Adv. Marques de los Velez s/n, 30008 Murcia, Spain."}], "LastName": "L\u00f3pez-Jornet", "ForeName": "P\u00eda", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto Murciano de Investigaci\u00f3n Biosanitaria (IMIB-Arrixaca-UMU), Cl\u00ednica Odontol\u00f3gica Universitaria Hospital Morales Meseguer, Adv. Marques de los Velez s/n, 30008 Murcia, Spain."}], "LastName": "Lopez", "ForeName": "Eduardo Pons-Fuster", "Initials": "EP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lahore College for Women University, Lahore, Pakistan."}], "LastName": "Harun", "ForeName": "Nidaa", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Al-Farabi Kazakh National University, Faculty of Chemistry and Chemical Technology, Almaty 050040, Kazakhstan."}], "LastName": "Yeskaliyeva", "ForeName": "Balakyz", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Health Sciences, Department of Medicinal and Aromatic Plants, Istanbul 34668, Turkey."}], "LastName": "Beyatli", "ForeName": "Ahmet", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Plant Biology Department, Taras Shevchenko National University of Kyiv, Institute of Biology, Volodymyrska Str., 64, Kyiv 01033, Ukraine."}, {"Identifier": [], "Affiliation": "Department of Plant Physiology, Slovak University of Agriculture, Nitra, A. Hlinku 2, 94976 Nitra, Slovakia."}], "LastName": "Sytar", "ForeName": "Oksana", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Plant Sciences, LCWU, Lahore 54000, Pakistan."}], "LastName": "Shaheen", "ForeName": "Shabnum", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institution \"Chinese-Tajik Innovation Center for Natural Products\", Academy of Sciences of the Republic of Tajikistan, Ayni 299/2, Dushanbe 734063, Tajikistan."}], "LastName": "Sharopov", "ForeName": "Farukh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Taheri", "ForeName": "Yasaman", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania."}], "LastName": "Docea", "ForeName": "Anca Oana", "Initials": "AO"}, {"Identifier": ["0000-0002-1523-9116"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania."}], "LastName": "Calina", "ForeName": "Daniela", "Initials": "D"}, {"Identifier": ["0000-0003-4174-4586"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong."}], "LastName": "Cho", "ForeName": "William C", "Initials": "WC"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Coumarins"}, {"RegistryNumber": "0", "NameOfSubstance": "Protective Agents"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anti-Infective Agents"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bacteria"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Coumarins"}, {"QualifierName": ["chemically induced", "drug therapy", "pathology"], "DescriptorName": "Edema"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Protective Agents"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Salehi B., Quispe C., Chamkhi I., et al. Pharmacological properties of chalcones: a review of preclinical including molecular mechanisms and clinical evidence. Frontiers in Pharmacology. 2021;11(2068) doi: 10.3389/fphar.2020.592654.", "ArticleIdList": ["10.3389/fphar.2020.592654", "PMC7849684", "33536909"]}, {"Citation": "Erb M., Kliebenstein D. J. Plant secondary metabolites as defenses, regulators, and primary metabolites: the blurred functional trichotomy. Plant Physiology. 2020;184(1):39\u201352. doi: 10.1104/pp.20.00433.", "ArticleIdList": ["10.1104/pp.20.00433", "PMC7479915", "32636341"]}, {"Citation": "Salehi B., Rescigno A., Dettori T., et al. Avocado-soybean unsaponifiables: a panoply of potentialities to be exploited. Biomolecules. 2020;10(1):p. 20.", "ArticleIdList": ["PMC7023362", "31940989"]}, {"Citation": "Sarker S. D., Nahar L. Progress in the chemistry of naturally occurring coumarins. Progress in the Chemistry of Organic Natural Products. 2017;106:241\u2013304. doi: 10.1007/978-3-319-59542-9_3.", "ArticleIdList": ["10.1007/978-3-319-59542-9_3", "28762091"]}, {"Citation": "Borges M. F., Roleira F. M., Milhazes N. J., Villare E. U., Penin L. S. Simple coumarins: privileged scaffolds in medicinal chemistry. Frontiers in Medicinal Chemistry. 2009;4:23\u201385."}, {"Citation": "Tava A. Coumarin-containing grass: volatiles from sweet vernalgrass (Anthoxanthum odoratum L.) Journal of Essential Oil Research. 2001;13(5):367\u2013370. doi: 10.1080/10412905.2001.9712236.", "ArticleIdList": ["10.1080/10412905.2001.9712236"]}, {"Citation": "Luo K., Jahufer M. Z., Wu F., et al. Genotypic variation in a breeding population of yellow sweet clover (Melilotus officinalis) Frontiers in Plant Science. 2016;7:p. 972.", "ArticleIdList": ["PMC4940390", "27462321"]}, {"Citation": "Blahov\u00e1 J., Svobodov\u00e1 Z. Assessment of coumarin levels in ground cinnamon available in the Czech retail market. The Scientific World Journal. 2012;2012:4. doi: 10.1100/2012/263851.263851", "ArticleIdList": ["10.1100/2012/263851", "PMC3385612", "22761548"]}, {"Citation": "Leal L. K., Ferreira A. A., Bezerra G. A., Matos F. J., Viana G. S. Antinociceptive, anti-inflammatory and bronchodilator activities of Brazilian medicinal plants containing coumarin: a comparative study. Journal of Ethnopharmacology. 2000;70(2):151\u2013159. doi: 10.1016/S0378-8741(99)00165-8.", "ArticleIdList": ["10.1016/S0378-8741(99)00165-8", "10771205"]}, {"Citation": "Poonam V., Raunak G. K., Reddy C. S. L., et al. Chemical constituents of the genus Prunus and their medicinal properties. Current Medicinal Chemistry. 2011;18(25):3758\u20133824. doi: 10.2174/092986711803414386.", "ArticleIdList": ["10.2174/092986711803414386", "21831039"]}, {"Citation": "Sharopov F., Setzer W. N. Medicinal plants of Tajikistan. In: Egamberdieva D., \u00d6zt\u00fcrk M., editors. Vegetation of Central Asia and environs. Switzerland: Springer Nature; 2018. pp. 163\u2013210."}, {"Citation": "Menezes J. C. J. M. D. S., Diederich M. F. Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology. European Journal of Medicinal Chemistry. 2019;182:p. 111637. doi: 10.1016/j.ejmech.2019.111637.", "ArticleIdList": ["10.1016/j.ejmech.2019.111637", "31494471"]}, {"Citation": "Al-Warhi T., Sabt A., Elkaeed E. B., Eldehna W. M. Recent advancements of coumarin-based anticancer agents: an up-to-date review. Bioorganic Chemistry. 2020;103:p. 104163. doi: 10.1016/j.bioorg.2020.104163.", "ArticleIdList": ["10.1016/j.bioorg.2020.104163", "32890989"]}, {"Citation": "Garg S. S., Gupta J., Sharma S., Sahu D. An insight into the therapeutic applications of coumarin compounds and their mechanisms of action. European Journal of Pharmaceutical Sciences. 2020;152:p. 105424. doi: 10.1016/j.ejps.2020.105424.", "ArticleIdList": ["10.1016/j.ejps.2020.105424", "32534193"]}, {"Citation": "Ma X., Jiang Y., Wen J., Zhao Y., Zeng J., Guo Y. A comprehensive review of natural products to fight liver fibrosis: alkaloids, terpenoids, glycosides, coumarins and other compounds. European Journal of Pharmacology. 2020;888:p. 173578. doi: 10.1016/j.ejphar.2020.173578.", "ArticleIdList": ["10.1016/j.ejphar.2020.173578", "32976828"]}, {"Citation": "Kadhum A. A., Al-Amiery A. A., Musa A. Y., Mohamad A. B. The antioxidant activity of new coumarin derivatives. International Journal of Molecular Sciences. 2011;12(9):5747\u20135761. doi: 10.3390/ijms12095747.", "ArticleIdList": ["10.3390/ijms12095747", "PMC3189748", "22016624"]}, {"Citation": "Bourgaud F., Hehn A., Larbat R., et al. Biosynthesis of coumarins in plants: a major pathway still to be unravelled for cytochrome P450 enzymes. Phytochemistry Reviews. 2006;5(2-3):293\u2013308. doi: 10.1007/s11101-006-9040-2.", "ArticleIdList": ["10.1007/s11101-006-9040-2"]}, {"Citation": "Shimizu B. 2-Oxoglutarate-dependent dioxygenases in the biosynthesis of simple coumarins. Frontiers in Plant Science. 2014;5:p. 549.", "ArticleIdList": ["PMC4217350", "25404933"]}, {"Citation": "Sharma R., Arya V. Review on fruits having anti-diabetic potential. Journal of Chemical and Pharmaceutical Research. 2011;3:204\u2013212."}, {"Citation": "Bubols G. B., Vianna Dda R., Medina-Remon A., et al. The antioxidant activity of coumarins and flavonoids. Mini Reviews in Medicinal Chemistry. 2013;13(3):318\u2013334. doi: 10.2174/138955713804999775.", "ArticleIdList": ["10.2174/138955713804999775", "22876957"]}, {"Citation": "Torres R., Faini F., Modak B., Urbina F., Labb\u00e9 C., Guerrero J. Antioxidant activity of coumarins and flavonols from the resinous exudate of Haplopappus multifolius. Phytochemistry. 2006;67(10):984\u2013987. doi: 10.1016/j.phytochem.2006.03.016.", "ArticleIdList": ["10.1016/j.phytochem.2006.03.016", "16684545"]}, {"Citation": "Al-Amiery A. A., Kadhum A. A. H., Mohamad A. A. Antifungal activities of new coumarins. Molecules. 2012;17(5):5713\u20135723. doi: 10.3390/molecules17055713.", "ArticleIdList": ["10.3390/molecules17055713", "PMC6268721", "22628043"]}, {"Citation": "Kirsch G., Abdelwahab A. B., Chaimbault P. Natural and synthetic coumarins with effects on inflammation. Molecules. 2016;21(10):p. 1322. doi: 10.3390/molecules21101322.", "ArticleIdList": ["10.3390/molecules21101322", "PMC6273422", "27706093"]}, {"Citation": "Kostova I. Synthetic and natural coumarins as cytotoxic agents. Current Medicinal Chemistry-Anti-Cancer Agents. 2005;5(1):29\u201346. doi: 10.2174/1568011053352550.", "ArticleIdList": ["10.2174/1568011053352550", "15720259"]}, {"Citation": "Chow S. C. Bioavailability and bioequivalence in drug development. Wiley Interdisciplinary Reviews: Computational Statistics. 2014;6(4):304\u2013312. doi: 10.1002/wics.1310.", "ArticleIdList": ["10.1002/wics.1310", "PMC4157693", "25215170"]}, {"Citation": "Dalton J. T., Yates C. R. Bioavailability of Drugs and Bioequivalence. In: Swarbrick J., editor. Encyclopedia of pharmaceutical technology. USA: Informa Healthcare; 2007. pp. 164\u2013176."}, {"Citation": "Ritschel W. A., Hoffmann K. A. Pilot study on bioavailability of coumarin and 7-hydroxycoumarin upon peroral administration of coumarin in a sustained-release dosage form. Journal of Clinical Pharmacology. 1981;21(7):294\u2013300. doi: 10.1002/j.1552-4604.1981.tb01770.x.", "ArticleIdList": ["10.1002/j.1552-4604.1981.tb01770.x", "7263928"]}, {"Citation": "Xie Q., Wang X., Wang X., Jiang Z., Qiu Z. Design, synthesis, and bioavailability evaluation of coumarin-based prodrug of meptazinol. Bioorganic & Medicinal Chemistry Letters. 2005;15(22):4953\u20134956. doi: 10.1016/j.bmcl.2005.08.016.", "ArticleIdList": ["10.1016/j.bmcl.2005.08.016", "16154745"]}, {"Citation": "Abraham K., Pfister M., W\u00f6hrlin F., Lampen A. Relative bioavailability of coumarin from cinnamon and cinnamon-containing foods compared to isolated coumarin: a four-way crossover study in human volunteers. Molecular Nutrition & Food Research. 2011;55(4):644\u2013653. doi: 10.1002/mnfr.201000394.", "ArticleIdList": ["10.1002/mnfr.201000394", "21462332"]}, {"Citation": "Escudero G. E., Laino C. H., Echeverr\u00eda G. A., et al. Improving the antidepressant action and the bioavailability of sertraline by co-crystallization with coumarin 3-carboxylate. Structural determination. Chemico-biological interactions. 2016;249:46\u201355. doi: 10.1016/j.cbi.2016.03.010.", "ArticleIdList": ["10.1016/j.cbi.2016.03.010", "26952715"]}, {"Citation": "Tripathi A., Misra K. Inhibition of P-glycoprotein mediated efflux of paclitaxel by coumarin derivatives in cancer stem cells: an in silico approach. Combinatorial Chemistry & High Throughput Screening. 2016;19(6):497\u2013506. doi: 10.2174/1386207319666160517115158.", "ArticleIdList": ["10.2174/1386207319666160517115158", "27185570"]}, {"Citation": "Lon\u010dar M., Jakovljevi\u0107 M., \u0160ubari\u0107 D., et al. Coumarins in food and methods of their determination. Food. 2020;9(5)", "ArticleIdList": ["PMC7278589", "32443406"]}, {"Citation": "Thomas V., Giles D., Basavarajaswamy G., Das A., Patel A. Coumarin derivatives as anti-inflammatory and anticancer agents. Anti-Cancer Agents in Medicinal Chemistry. 2017;17(3):415\u2013423. doi: 10.2174/1871520616666160902094739.", "ArticleIdList": ["10.2174/1871520616666160902094739", "27592545"]}, {"Citation": "Witaicenis A., Seito L. N., Di Stasi L. C. Intestinal anti-inflammatory activity of esculetin and 4-methylesculetin in the trinitrobenzenesulphonic acid model of rat colitis. Chemico-Biological Interactions. 2010;186(2):211\u2013218. doi: 10.1016/j.cbi.2010.03.045.", "ArticleIdList": ["10.1016/j.cbi.2010.03.045", "20380826"]}, {"Citation": "Venugopala K. N., Rashmi V., Odhav B. Review on natural coumarin lead compounds for their pharmacological activity. BioMed Research International. 2013;2013:14. doi: 10.1155/2013/963248.963248", "ArticleIdList": ["10.1155/2013/963248", "PMC3622347", "23586066"]}, {"Citation": "Wang C. M., Zhou W., Li C. X., Chen H., Shi Z. Q., Fan Y. J. Efficacy of osthol, a potent coumarin compound, in controlling powdery mildew caused by Sphaerotheca fuliginea. Journal of Asian Natural Products Research. 2009;11(9):783\u2013791. doi: 10.1080/10286020903158964.", "ArticleIdList": ["10.1080/10286020903158964", "20183325"]}, {"Citation": "Numonov S., Sharopov F. S., Atolikhshoeva S., et al. Volatile secondary metabolites with potent antidiabetic activity from the roots of Prangos pabularia Lindl.\u2014Computational and experimental investigations. Applied Sciences. 2019;9(11):p. 2362. doi: 10.3390/app9112362.", "ArticleIdList": ["10.3390/app9112362"]}, {"Citation": "May J. M., Owens T. W., Mandler M. D., et al. The antibiotic novobiocin binds and activates the ATPase that powers lipopolysaccharide transport. Journal of the American Chemical Society. 2017;139(48):17221\u201317224. doi: 10.1021/jacs.7b07736.", "ArticleIdList": ["10.1021/jacs.7b07736", "PMC5735422", "29135241"]}, {"Citation": "Feng D., Zhang A., Yang Y., Yang P. Coumarin-containing hybrids and their antibacterial activities. Archiv der Pharmazie. 2020;353(6, article e1900380) doi: 10.1002/ardp.201900380.", "ArticleIdList": ["10.1002/ardp.201900380", "32253782"]}, {"Citation": "Portugal J. Chartreusin, elsamicin A and related anti-cancer antibiotics. Current Medicinal Chemistry. 2003;3(6):411\u2013420. doi: 10.2174/1568011033482215.", "ArticleIdList": ["10.2174/1568011033482215", "14529449"]}, {"Citation": "Whang W. K., Park H. S., Ham I. Natural compounds, fraxin and chemicals structurally related to fraxin protect cells from oxidative stress. Experimental and Molecular Medicine. 2005;37(5):436\u2013446. doi: 10.1038/emm.2005.54.", "ArticleIdList": ["10.1038/emm.2005.54", "16264268"]}, {"Citation": "Chiang C. C., Cheng M. J., Peng C. F., Huang H. Y., Chen I. S. A novel dimeric coumarin analog and antimycobacterial constituents from Fatoua pilosa. Chemistry and Biodiversity. 2010;7(7):1728\u20131736. doi: 10.1002/cbdv.200900326.", "ArticleIdList": ["10.1002/cbdv.200900326", "20658660"]}, {"Citation": "Majnooni M. B., Fakhri S., Shokoohinia Y., Mojarrab M., Kazemi-Afrakoti S., Farzaei M. H. Isofraxidin: synthesis, biosynthesis, isolation, pharmacokinetic and pharmacological properties. Molecules. 2020;25(9):p. 2040. doi: 10.3390/molecules25092040.", "ArticleIdList": ["10.3390/molecules25092040", "PMC7248759", "32349420"]}, {"Citation": "Kuo P. C., Hsu M. Y., Damu A. G., et al. Flavonoids and coumarins from leaves of Phellodendron chinense. Planta Medica. 2004;70(2):183\u2013185. doi: 10.1055/s-2004-815500.", "ArticleIdList": ["10.1055/s-2004-815500", "14994201"]}, {"Citation": "Shin E., Choi K. M., Yoo H. S., Lee C. K., Hwang B. Y., Lee M. K. Inhibitory effects of coumarins from the stem barks of Fraxinus rhynchophylla on adipocyte differentiation in 3T3-L1 cells. Biological and Pharmaceutical Bulletin. 2010;33(9):1610\u20131614. doi: 10.1248/bpb.33.1610.", "ArticleIdList": ["10.1248/bpb.33.1610", "20823583"]}, {"Citation": "Grabarska A., Skalicka-Wo\u017aniak K., Kie\u0142bus M., et al. Imperatorin as a promising chemotherapeutic agent against human larynx cancer and rhabdomyosarcoma cells. Molecules. 2020;25(9):p. 2046.", "ArticleIdList": ["PMC7248852", "32353989"]}, {"Citation": "Kharasch E. D., Hankins D. C., Taraday J. K. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity. Drug Metabolism and Disposition. 2000;28(1):28\u201333.", "ArticleIdList": ["10611136"]}, {"Citation": "Chakthong S., Weaaryee P., Puangphet P. Alkaloid and coumarins from the green fruits of _Aegle marmelos_. Phytochemistry. 2012;75:108\u2013113. doi: 10.1016/j.phytochem.2011.11.018.", "ArticleIdList": ["10.1016/j.phytochem.2011.11.018", "22196941"]}, {"Citation": "Rosselli S., Maggio A. M., Faraone N. The cytotoxic properties of natural coumarins isolated from roots of Ferulago campestris (Apiaceae) and of synthetic ester derivatives of aegelinol. Natural Product Communications. 2009;4(12):1701\u20131706.", "ArticleIdList": ["20120111"]}, {"Citation": "Basile A., Sorbo S., Spadaro V., et al. Antimicrobial and antioxidant activities of coumarins from the roots of Ferulago campestris (Apiaceae) Molecules. 2009;14(3):939\u2013952. doi: 10.3390/molecules14030939.", "ArticleIdList": ["10.3390/molecules14030939", "PMC6253837", "19255552"]}, {"Citation": "Patil A. D., Freyer A. J., Eggleston D. S., et al. The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn. Journal of Medicinal Chemistry. 1993;36(26):4131\u20134138. doi: 10.1021/jm00078a001.", "ArticleIdList": ["10.1021/jm00078a001", "7506311"]}, {"Citation": "Kashman Y., Gustafson K. R., Fuller R. W., et al. HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. Journal of Medicinal Chemistry. 1992;35(15):2735\u20132743. doi: 10.1021/jm00093a004.", "ArticleIdList": ["10.1021/jm00093a004", "1379639"]}, {"Citation": "Newman R. A., Chen W., Madden T. L. Pharmaceutical properties of related calanolide compounds with activity against human immunodeficiency virus. Journal of Pharmaceutical Sciences. 1998;87(9):1077\u20131080. doi: 10.1021/js980122d.", "ArticleIdList": ["10.1021/js980122d", "9724557"]}, {"Citation": "McKee T. C., Fuller R. W., Covington C. D., et al. New pyranocoumarins isolated from Calophyllum lanigerum and Calophyllum teysmannii. Journal of Natural Products. 1996;59(8):754\u2013758. doi: 10.1021/np9603784.", "ArticleIdList": ["10.1021/np9603784", "8792623"]}, {"Citation": "Timson D. J. Dicoumarol: a drug which hits at least two very different targets in vitamin K metabolism. Current Drug Targets. 2017;18(5):500\u2013510. doi: 10.2174/1389450116666150722141906.", "ArticleIdList": ["10.2174/1389450116666150722141906", "26201483"]}, {"Citation": "Ren Q. C., Gao C., Xu Z., et al. Bis-coumarin derivatives and their biological activities. Current Topics in Medicinal Chemistry. 2018;18(2):101\u2013113. doi: 10.2174/1568026618666180221114515.", "ArticleIdList": ["10.2174/1568026618666180221114515", "29473509"]}, {"Citation": "Eichinger S. Reversing vitamin K antagonists: making the old new again. Hematology. American Society of Hematology. Education Program. 2016;2016(1):605\u2013611.", "ArticleIdList": ["PMC6142521", "27913535"]}, {"Citation": "Mart\u00ednez-P\u00e9rez E. F., Ju\u00e1rez Z. N., Hern\u00e1ndez L. R., Bach H. Natural antispasmodics: source, stereochemical configuration, and biological activity. BioMed Research International. 2018;2018:32. doi: 10.1155/2018/3819714.3819714", "ArticleIdList": ["10.1155/2018/3819714", "PMC6196993", "30402474"]}, {"Citation": "Khalil N., Bishr M., Desouky S., Salama O. Ammi visnaga L., a potential medicinal plant: a review. Molecules. 2020;25(2):p. 301. doi: 10.3390/molecules25020301.", "ArticleIdList": ["10.3390/molecules25020301", "PMC7024292", "31940874"]}, {"Citation": "El-Sharkawy E., Selim Y. Three new coumarin types from aerial parts of Ammi majus L.. and their cytotoxic activity. Zeitschrift fuer Naturforschung, C: Journal of Biosciences. 2018;73(1-2):1\u20137. doi: 10.1515/znc-2017-0068.", "ArticleIdList": ["10.1515/znc-2017-0068", "28771441"]}, {"Citation": "Hsia C.-W., Lin K. C., Lee T. Y., et al. Esculetin, a coumarin derivative, prevents thrombosis: inhibitory signaling on PLC\u03b32-PKC-AKT activation in human platelets. International Journal of Molecular Sciences. 2019;20(11):p. 2731. doi: 10.3390/ijms20112731.", "ArticleIdList": ["10.3390/ijms20112731", "PMC6600380", "31163690"]}, {"Citation": "Liang C., Ju W., Pei S., Tang Y., Xiao Y. Pharmacological activities and synthesis of esculetin and its derivatives: a mini-review. Molecules. 2017;22(3):p. 387. doi: 10.3390/molecules22030387.", "ArticleIdList": ["10.3390/molecules22030387", "PMC6155195", "28257115"]}, {"Citation": "Iranshahi M. E., Askari M., Sahebkar A., Hadjipavlou L. D. Evaluation of antioxidant, anti-inflammatory and lipoxygenase inhibitory activities of the prenylated coumarin umbelliprenin. Daru. 2009;17:99\u2013103."}, {"Citation": "Egan D., O'kennedy R., Moran E., Cox D., Prosser E., Thornes R. D. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metabolism Reviews. 1990;22(5):503\u2013529. doi: 10.3109/03602539008991449.", "ArticleIdList": ["10.3109/03602539008991449", "2078993"]}, {"Citation": "Marshall M. E., Butler K., Hermansen D. Structural modification of coumarin for increased anti-coagulation potency. Prostate. 1990;17(2):95\u201399. doi: 10.1002/pros.2990170203.", "ArticleIdList": ["10.1002/pros.2990170203", "2399194"]}, {"Citation": "Padureanu R., Albu C. V., Mititelu R. R., et al. Oxidative stress and inflammation interdependence in multiple sclerosis. Journal of Clinical Medicine. 2019;8(11):p. 11.", "ArticleIdList": ["PMC6912446", "31683787"]}, {"Citation": "Rogoveanu O. C., Calina D., Cucu M. G., et al. Association of cytokine gene polymorphisms with osteoarthritis susceptibility. Experimental and Therapeutic Medicine. 2018;16(3):2659\u20132664. doi: 10.3892/etm.2018.6477.", "ArticleIdList": ["10.3892/etm.2018.6477", "PMC6122495", "30186498"]}, {"Citation": "Docea A. O., Calina D., Buga A. M., et al. The effect of silver nanoparticles on antioxidant/pro-oxidant balance in a murine model. International Journal of Molecular Sciences. 2020;21(4):p. 17.", "ArticleIdList": ["PMC7072874", "32059471"]}, {"Citation": "Scheau C., Caruntu C., Badarau I. A., et al. Cannabinoids and inflammations of the gut-lung-skin barrier. Journal of Personalized Medicine. 2021;11(6):p. 494. doi: 10.3390/jpm11060494.", "ArticleIdList": ["10.3390/jpm11060494", "PMC8227007", "34072930"]}, {"Citation": "Huang G. J., Deng J. S., Liao J. C., et al. Inducible nitric oxide synthase and cyclooxygenase-2 participate in anti-inflammatory activity of imperatorin from Glehnia littoralis. Journal of Agricultural and Food Chemistry. 2012;60(7):1673\u20131681. doi: 10.1021/jf204297e.", "ArticleIdList": ["10.1021/jf204297e", "22188242"]}, {"Citation": "Kwon O. S., Choi J. S., Islam M. N., Kim Y. S., Kim H. P. Inhibition of 5-lipoxygenase and skin inflammation by the aerial parts of Artemisia capillaris and its constituents. Archives of Pharmacal Research. 2011;34(9):1561\u20131569. doi: 10.1007/s12272-011-0919-0.", "ArticleIdList": ["10.1007/s12272-011-0919-0", "21975819"]}, {"Citation": "Borman P. Lymphedema diagnosis, treatment, and follow-up from the view point of physical medicine and rehabilitation specialists. Turkish journal of physical medicine and rehabilitation. 2018;64(3):179\u2013197.", "ArticleIdList": ["PMC6657795", "31453511"]}, {"Citation": "Sharifi-Rad M., Anil Kumar N. V., Zucca P., et al. Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Frontiers in Physiology. 2020;11:p. 21.", "ArticleIdList": ["PMC7347016", "32714204"]}, {"Citation": "Sharifi-Rad J., Quispe C., Shaheen S., et al. Flavonoids as potential anti-platelet aggregation agents: from biochemistry to health promoting abilities. Critical Reviews in Food Science and Nutrition. 2021:1\u201314. doi: 10.1080/10408398.2021.1924612.", "ArticleIdList": ["10.1080/10408398.2021.1924612", "33983094"]}, {"Citation": "Wojciechowski V. V., Calina D., Tsarouhas K., et al. A guide to acquired vitamin K coagulophathy diagnosis and treatment: the Russian perspective. Daru. 2017;25(1):p. 10. doi: 10.1186/s40199-017-0175-z.", "ArticleIdList": ["10.1186/s40199-017-0175-z", "PMC5393004", "28416008"]}, {"Citation": "Buga A. M., Docea A. O., Albu C., et al. Molecular and cellular stratagem of brain metastases associated with melanoma. Oncology Letters. 2019;17(5):4170\u20134175.", "ArticleIdList": ["PMC6444343", "30944612"]}, {"Citation": "Mitrut P. Colorectal cancer and inflammatory bowel disease. In: Rodrigo L., editor. Colorectal Cancer - from Pathogenesis to Treatment. Rijeka: Intech Europe; 2016. pp. 185\u2013199."}, {"Citation": "Sharifi-Rad J., Rodrigues C. F., Stojanovi\u0107-Radi\u0107 Z., et al. Probiotics: versatile bioactive components in promoting human health. Medicina-Lithuania. 2020;56(9):p. 30.", "ArticleIdList": ["PMC7560221", "32867260"]}, {"Citation": "Mahler J. L., Gomella L. G., Crawford E. D., Glode L. M., Zippe C. D., Fair W. R. Synthesis of novel coumarin bisindole derivatives & reported as anti-hyperlipidimic activity. Prostate. 1992;20:112\u2013123.", "ArticleIdList": ["1549551"]}, {"Citation": "Yang D., Gu T., Wang T., Tang Q., Ma C. Effects of osthole on migration and invasion in breast cancer cells. Bioscience, Biotechnology, and Biochemistry. 2010;74(7):1430\u20131434. doi: 10.1271/bbb.100110.", "ArticleIdList": ["10.1271/bbb.100110", "20622464"]}, {"Citation": "Yun E. S., Park S. S., Shin H. C., Choi Y. H., Kim W. J., Moon S. K. p38 MAPK activation is required for esculetin-induced inhibition of vascular smooth muscle cells proliferation. Toxicology In Vitro. 2011;25(7):1335\u20131342. doi: 10.1016/j.tiv.2011.05.001.", "ArticleIdList": ["10.1016/j.tiv.2011.05.001", "21600278"]}, {"Citation": "Lee C. R., Shin E. J., Kim H. C., Choi Y. S., Shin T., Wie M. B. Esculetin inhibits N-methyl-D-aspartate neurotoxicity via glutathione preservation in primary cortical cultures. Laboratory Animal Research. 2011;27(3):259\u2013263. doi: 10.5625/lar.2011.27.3.259.", "ArticleIdList": ["10.5625/lar.2011.27.3.259", "PMC3188735", "21998617"]}, {"Citation": "Zlatian O., Balasoiu A. T., Balasoiu M., et al. Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections. Experimental and Therapeutic Medicine. 2018;16(6):4499\u20134510. doi: 10.3892/etm.2018.6737.", "ArticleIdList": ["10.3892/etm.2018.6737", "PMC6257814", "30542398"]}, {"Citation": "C\u0103lina D. A., Ro\u0219u L. U., Ro\u0219u A. F., et al. Etiological diagnosis and pharmacotherapeutic management of parapneumonic pleurisy. Farm\u00e1cia. 2016;64(6):946\u2013952."}, {"Citation": "Salehi B., Sharifi-Rad J., Capanoglu E., et al. Cucurbita plants: from farm to industry. Applied Sciences-Basel. 2019;9(16):p. 21."}, {"Citation": "Salehi B., Shivaprasad Shetty M., Anil Kumar V. N., et al. Veronica plants-drifting from farm to traditional healing, food application, and phytopharmacology. Molecules. 2019;24(13):p. 35.", "ArticleIdList": ["PMC6651156", "31277407"]}, {"Citation": "Salehi B., Prakash Mishra A., Nigam M., et al. Ficus plants: state of the art from a phytochemical, pharmacological, and toxicological perspective. Phytotherapy Research. 2021;35(3):1187\u20131217. doi: 10.1002/ptr.6884.", "ArticleIdList": ["10.1002/ptr.6884", "33025667"]}, {"Citation": "C\u0103lina D., Docea A. O., Rosu L., et al. Antimicrobial resistance development following surgical site infections. Molecular Medicine Reports. 2017;15(2):681\u2013688. doi: 10.3892/mmr.2016.6034.", "ArticleIdList": ["10.3892/mmr.2016.6034", "PMC5364857", "27959419"]}, {"Citation": "Reen F. J., Guti\u00e9rrez-Barranquero J. A., Parages M. L., O\u00b4Gara F. Coumarin: a novel player in microbial quorum sensing and biofilm formation inhibition. Applied Microbiology and Biotechnology. 2018;102(5):2063\u20132073. doi: 10.1007/s00253-018-8787-x.", "ArticleIdList": ["10.1007/s00253-018-8787-x", "PMC5814477", "29392389"]}, {"Citation": "Evans W. C. Trease and Evans Pharmacognosy. 16th. Elsevier Ltd; 2009."}, {"Citation": "Baek N. I., Ahn E. M., Kim H. Y., Park Y. D. Furanocoumarins from the root of Angelica dahurica. Archives of Pharmacal Research. 2000;23:467\u2013470.", "ArticleIdList": ["11059825"]}, {"Citation": "Raja S. B., Murali M. R., Roopa K., Devaraj S. N. Imperatorin a furocoumarin inhibits periplasmic Cu-Zn SOD of Shigella dysenteriae their by modulates its resistance towards phagocytosis during host pathogen interaction. Biomedicine & Pharmacotherapy. 2011;65(8):560\u2013568. doi: 10.1016/j.biopha.2010.10.010.", "ArticleIdList": ["10.1016/j.biopha.2010.10.010", "21194882"]}, {"Citation": "Chou S. Y., Hsu C. S., Wang K. T., Wang M. C., Wang C. C. Antitumor effects of osthol from Cnidium monnieri: an in vitro and in vivo study. Phytotherapy Research. 2007;21:226\u2013230.", "ArticleIdList": ["17154232"]}, {"Citation": "Cisowski W., Sawicka U., Mardarowiczb M., Asztemborskac M., \u0141uczkiewiczd M. Essential oil from herb and rhizome of Peucedanum ostruthium (L. Koch.) ex DC. Zeitschrift f\u00fcr Naturforschung C. 2001;56(11-12):930\u2013932. doi: 10.1515/znc-2001-11-1202.", "ArticleIdList": ["10.1515/znc-2001-11-1202", "11837677"]}, {"Citation": "Mishra S., Pandey A., Manvati S. Coumarin: an emerging antiviral agent. Heliyon. 2020;6(1):p. e03217.", "ArticleIdList": ["PMC7002824", "32042967"]}, {"Citation": "Stout G. H., Stevens K. L. The structure of costatolide. Journal of Organic Chemistry. 1964;29(12):3604\u20133609. doi: 10.1021/jo01035a041.", "ArticleIdList": ["10.1021/jo01035a041"]}, {"Citation": "Spino C., Dodier M., Sotheeswaran S. Anti-HIV coumarins from calophyllum seed oil. Bioorganic and Medicinal Chemistry Letters. 1998;8:3475\u20133478.", "ArticleIdList": ["9934455"]}, {"Citation": "Sancho R., M\u00e1rquez N., G\u00f3mez-Gonzalo M., et al. Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway. The Journal of Biological Chemistry. 2004;279:7349\u201337359.", "ArticleIdList": ["15218031"]}, {"Citation": "Neyts J., Clercq E. D., Singha R., et al. Structure\u2212Activity relationship of new anti-Hepatitis C virus agents: Heterobicycle\u2212Coumarin conjugates. Journal of medicinal chemistry. 2009;52(5):1486\u20131490. doi: 10.1021/jm801240d.", "ArticleIdList": ["10.1021/jm801240d", "19193060"]}, {"Citation": "Hassan M. Z., Osman H., Ali M. A., Ahsan M. J. Therapeutic potential of coumarins as antiviral agents. European Journal of Medicinal Chemistry. 2016;123:236\u2013255. doi: 10.1016/j.ejmech.2016.07.056.", "ArticleIdList": ["10.1016/j.ejmech.2016.07.056", "PMC7115672", "27484512"]}, {"Citation": "Islam M. S., Quispe C., Hossain R., et al. Neuropharmacological effects of quercetin: a literature-based review. Frontiers in Pharmacology. 2021;12:p. 1533.", "ArticleIdList": ["PMC8248808", "34220504"]}, {"Citation": "Tsatsakis A., Docea A. O., Calina D., et al. A mechanistic and pathophysiological approach for stroke associated with drugs of abuse. Journal of Clinical Medicine. 2019;8(9):p. 36.", "ArticleIdList": ["PMC6780697", "31450861"]}, {"Citation": "Salehi B., Sharifi-Rad J., Cappellini F., et al. The therapeutic potential of anthocyanins: current approaches based on their molecular mechanism of action. Frontiers in Pharmacology. 2020;11:p. 20.", "ArticleIdList": ["PMC7479177", "32982731"]}, {"Citation": "Salehi B., Sestito S., Rapposelli S., et al. Epibatidine: a promising natural alkaloid in health. Biomolecules. 2019;9(1):p. 10.", "ArticleIdList": ["PMC6359223", "30583611"]}, {"Citation": "Calina D., Buga A. M., Mitroi M., et al. The treatment of cognitive, behavioural and motor impairments from brain injury and neurodegenerative diseases through cannabinoid system modulation-evidence from in vivo studies. Journal of Clinical Medicine. 2020;9(8):p. 28.", "ArticleIdList": ["PMC7464236", "32726998"]}, {"Citation": "Hu Y. H., Yang J., Zhang Y., et al. Synthesis and biological evaluation of 3-(4-aminophenyl)-coumarin derivatives as potential anti-Alzheimer's disease agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 2019;34(1):1083\u20131092. doi: 10.1080/14756366.2019.1615484.", "ArticleIdList": ["10.1080/14756366.2019.1615484", "PMC6534212", "31117844"]}, {"Citation": "Matos M. J., Vilar S., Gonzalez-Franco R. M., et al. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study. European Journal of Medicinal Chemistry. 2013;63:151\u2013161. doi: 10.1016/j.ejmech.2013.02.009.", "ArticleIdList": ["10.1016/j.ejmech.2013.02.009", "23474901"]}, {"Citation": "Wang C., Pei A., Chen J., et al. A natural coumarin derivative esculetin offers neuroprotection on cerebral ischemia/reperfusion injury in mice. Journal of Neurochemistry. 2012;121(6):1007\u20131013. doi: 10.1111/j.1471-4159.2012.07744.x.", "ArticleIdList": ["10.1111/j.1471-4159.2012.07744.x", "22458555"]}, {"Citation": "Huang M., Xie S. S., Jiang N., Lan J. S., Kong L. Y., Wang X. B. Multifunctional coumarin derivatives: monoamine oxidase B (MAO-B) inhibition, anti-\u03b2-amyloid (A\u03b2) aggregation and metal chelation properties against Alzheimer\u2019s disease. Bioorganic & Medicinal Chemistry Letters. 2015;25(3):508\u2013513. doi: 10.1016/j.bmcl.2014.12.034.", "ArticleIdList": ["10.1016/j.bmcl.2014.12.034", "25542589"]}, {"Citation": "Li H., Yao Y., Li L. Coumarins as potential antidiabetic agents. The Journal of Pharmacy and Pharmacology. 2017;69(10):1253\u20131264. doi: 10.1111/jphp.12774.", "ArticleIdList": ["10.1111/jphp.12774", "28675434"]}, {"Citation": "Cannon C. P., Gropper S., Bhatt D. L., et al. RE-DUAL PCI steering committee and investigators. Design and rationale of the RE-DUAL PCI trial: a prospective, randomized, phase 3b study comparing the safety and efficacy of dual antithrombotic therapy with dabigatran etexilate versus warfarin triple therapy in patients with nonvalvular atrial fibrillation who have undergone percutaneous coronary intervention with stenting. Clinical Cardiology. 2016;39:555\u2013564.", "ArticleIdList": ["PMC5108471", "27565018"]}, {"Citation": "Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Circulation. 1991;84:527\u2013539.", "ArticleIdList": ["1860198"]}, {"Citation": "Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo controlled randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation, The Copenhagen AFASAK study. Lancet. 1989;1(8631):175\u2013179. doi: 10.1016/s0140-6736(89)91200-2.", "ArticleIdList": ["10.1016/s0140-6736(89)91200-2", "2563096"]}, {"Citation": "Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The New England Journal of Medicine. 1990;323:1505\u20131511.", "ArticleIdList": ["2233931"]}, {"Citation": "Connolly S. J., Laupacis A., Gent M., Roberts R. S., Cairns J. A., Joyner C. Canadian atrial fibrillation anticoagulation (CAFA) study. Journal of the American College of Cardiology. 1991;18(2):349\u2013355. doi: 10.1016/0735-1097(91)90585-W.", "ArticleIdList": ["10.1016/0735-1097(91)90585-W", "1856403"]}, {"Citation": "Ezekowitz M. D., Bridgers S. L., James K. E., et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. The New England Journal of Medicine. 1992;327(20):1406\u20131412. doi: 10.1056/NEJM199211123272002.", "ArticleIdList": ["10.1056/NEJM199211123272002", "1406859"]}, {"Citation": "EAFT FT. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993;342:1255\u20131262.", "ArticleIdList": ["7901582"]}, {"Citation": "Hart R. G., Pearce L. A., Aguilar M. I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine. 2007;146:857\u2013867.", "ArticleIdList": ["17577005"]}, {"Citation": "Prins M. H., Lensing A. W., Bauersachs R., et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thrombosis journal. 2013;11:p. 21.", "ArticleIdList": ["PMC3850944", "24053656"]}, {"Citation": "Lee A. Y., Levine M. N., Baker R. I., et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. The New England Journal of Medicine. 2003;349(2):146\u2013153. doi: 10.1056/NEJMoa025313.", "ArticleIdList": ["10.1056/NEJMoa025313", "12853587"]}, {"Citation": "Woodruff S., Lee A. Y. Y., Carrier M., Feug\u00e8re G., Abreu P., Heissler J. Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT study. Journal of Thrombosis and Thrombolysis. 2019;47(4):495\u2013504. doi: 10.1007/s11239-019-01833-w.", "ArticleIdList": ["10.1007/s11239-019-01833-w", "PMC6476994", "30859370"]}, {"Citation": "Woodruff S., Feug\u00e8re G., Abreu P., Heissler J., Ruiz M. T., Jen F. A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment. Journal of Thrombosis and Thrombolysis. 2016;42(4):494\u2013504. doi: 10.1007/s11239-016-1386-8.", "ArticleIdList": ["10.1007/s11239-016-1386-8", "PMC5040733", "27344439"]}, {"Citation": "Ntaios G., Papavasileiou V., Makaritsis K., Vemmos K., Michel P., Lip G. Y. H. Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic review and meta-analysis. Stroke. 2017;48(9):2494\u20132503. doi: 10.1161/STROKEAHA.117.017549.", "ArticleIdList": ["10.1161/STROKEAHA.117.017549", "28716982"]}, {"Citation": "Esteve-Pastor M. A., Rivera-Caravaca J. M., Rold\u00e1n V., et al. Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: a comparison with optimally acenocoumarol anticoagulated patients. International journal of cardiology. 2018;254:125\u2013131.", "ArticleIdList": ["29248163"]}, {"Citation": "Gr\u00f6tz K. A., W\u00fcstenberg P., Kohnen R., et al. Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer-a prospective, randomized, placebo controlled, double-blind study. The British Journal of Oral & Maxillofacial Surgery. 2001;39:34\u201339.", "ArticleIdList": ["11178853"]}, {"Citation": "Thornes R. D., Daly L., Lynch G., et al. Treatment with coumarin to prevent or delay recurrence of malignant melanoma. Journal of cancer research and clinical oncology. 1994;120:32\u201334.", "ArticleIdList": ["8132701"]}, {"Citation": "Thornes R. D., Lynch G., Sheehan M. W. Cimetidine and coumarin therapy of melanoma. Lancet. 1982;320(8293):p. 328. doi: 10.1016/S0140-6736(82)90295-1.", "ArticleIdList": ["10.1016/S0140-6736(82)90295-1", "6124738"]}, {"Citation": "Dexeus F. H., Logothetis C. J., Sella A., et al. Phase II study of coumarin and cimetidine in patients with metastatic renal-cell carcinoma. Journal of Clinical Oncology. 1990;8(2):325\u2013329. doi: 10.1200/JCO.1990.8.2.325.", "ArticleIdList": ["10.1200/JCO.1990.8.2.325", "2137163"]}, {"Citation": "Kokron O., Maca S., Gasser G., Schmidt P. R. Cimetidine and coumarin therapy of renal cell carcinoma. Oncology. 1991;48:102\u2013106.", "ArticleIdList": ["1997930"]}, {"Citation": "Marshall M. E., Butler K., Hermansen D. Treatment of hormone refractory stage-D carcinoma of prostate with coumarin (1, 2- benzopyrone) and cimetidine: a pilot study. Prostate. 1990;17:95\u201399.", "ArticleIdList": ["2399194"]}, {"Citation": "Mousa S. Anticoagulants in thrombosis and cancer: the missing link. Expert Review of Anticancer Therapy. 2002;2(2):227\u2013233. doi: 10.1586/14737140.2.2.227.", "ArticleIdList": ["10.1586/14737140.2.2.227", "12113244"]}, {"Citation": "Zacharski L. R., Henderson W. G., Rickles F. R., et al. Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. JAMA. 1981;245:831\u2013835.", "ArticleIdList": ["6257941"]}, {"Citation": "Zacharski L. R., Henderson W. G., Rickles F. R., et al. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer. 1984;53:2046\u20132052.", "ArticleIdList": ["6322957"]}, {"Citation": "Chahinian A. P., Propert K. J., Ware J. H., et al. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. Journal of Clinical Oncology. 1989;7(8):993\u20131002. doi: 10.1200/JCO.1989.7.8.993.", "ArticleIdList": ["10.1200/JCO.1989.7.8.993", "2547030"]}, {"Citation": "Silberberg J. M., Zucker S. Warfarin anticoagulation for small-cell lung cancer: evidence against a cytotoxic or anticoagulant mechanism. Journal of Clinical Oncology. 1990;8(1):182\u2013184. doi: 10.1200/JCO.1990.8.1.182.", "ArticleIdList": ["10.1200/JCO.1990.8.1.182", "2153191"]}, {"Citation": "Haaland G. S., Falk R. S., Straume O., Lorens J. B. Association of warfarin use with lower overall cancer incidence among patients older than 50 years. JAMA Internal Medicine. 2017;177(12):1774\u20131780. doi: 10.1001/jamainternmed.2017.5512.", "ArticleIdList": ["10.1001/jamainternmed.2017.5512", "PMC5820735", "29114736"]}, {"Citation": "Kahale L. A., Hakoum M. B., Tsolakian I. G., et al. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database of Systematic Reviews. 2017;12, article CD006466", "ArticleIdList": ["PMC6389337", "29285754"]}, {"Citation": "Daly L. The first international urokinase/warfarin trial in colorectal cancer. Clinical & Experimental Metastasis. 1991;9(1):3\u201311. doi: 10.1007/BF01831705.", "ArticleIdList": ["10.1007/BF01831705", "2015715"]}, {"Citation": "Levine M., Hirsh J., Arnold A., et al. Double-blind randomized trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet. 1994;343:886\u2013889.", "ArticleIdList": ["7908358"]}, {"Citation": "Stanford C. F. Anticoagulants in the treatment of small cell carcinoma of the bronchus. Thorax. 1979;34(1):113\u2013116. doi: 10.1136/thx.34.1.113.", "ArticleIdList": ["10.1136/thx.34.1.113", "PMC471018", "375459"]}, {"Citation": "Maurer L. H., Herndon J. E., 2nd, Hollis D. R., et al. Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a cancer and leukemia group B study. Journal of Clinical Oncology. 1997;15(11):3378\u20133387. doi: 10.1200/JCO.1997.15.11.3378.", "ArticleIdList": ["10.1200/JCO.1997.15.11.3378", "9363869"]}, {"Citation": "Zlatian O. M., Com\u0103nescu M. V., Ro\u015fu A. F., et al. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer. Romanian Journal of Morphology and Embryology. 2015;56(1):175\u2013181.", "ArticleIdList": ["25826503"]}, {"Citation": "Docea A. O., Mitru\u0163 P., Grigore D., Pirici D., C\u0103lina D. C., Gofi\u0163\u0103 E. Immunohistochemical expression of TGF beta (TGF-beta), TGF beta receptor 1 (TGFBR1), and Ki67 in intestinal variant of gastric adenocarcinomas. Romanian Journal of Morphology and Embryology. 2012;53(3):683\u2013692.", "ArticleIdList": ["23188426"]}, {"Citation": "Skok \u017d., Zidar N., Kikelj D., Ila\u0161 J. Dual inhibitors of human DNA topoisomerase II and other cancer-related targets. Journal of Medicinal Chemistry. 2020;63(3):884\u2013904. doi: 10.1021/acs.jmedchem.9b00726.", "ArticleIdList": ["10.1021/acs.jmedchem.9b00726", "31592646"]}, {"Citation": "Agarwal R. Synthesis & biological screening of some novel. Coumarin derivatives. Biochemical Pharmacology. 2000;6:1042\u20131051."}, {"Citation": "EMA. Assessment report on Citrus bergamia Risso et Poiteau, aetheroleum. 2012  https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-citrus-bergamia-risso-et-poiteau-aetheroleum_en.pdf."}, {"Citation": "Salehi B., Lopez-Jornet P., Pons-Fuster L\u00f3pez E., et al. Plant-derived bioactives in oral mucosal lesions: a key emphasis to curcumin, lycopene, chamomile, aloe vera, green tea and coffee properties. Biomolecules. 2019;9(3):p. 23.", "ArticleIdList": ["PMC6468600", "30884918"]}, {"Citation": "Anand S. S., Yusuf S. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. JAMA. 1999;282(21):2058\u20132067. doi: 10.1001/jama.282.21.2058.", "ArticleIdList": ["10.1001/jama.282.21.2058", "10591389"]}, {"Citation": "Witt D. M. Approaches to optimal dosing of vitamin K antagonists. Seminars in Thrombosis and Hemostasis. 2012;38:667\u2013672.", "ArticleIdList": ["22893509"]}, {"Citation": "Ufer M. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol. Clinical Pharmacokinetics. 2005;44(12):1227\u20131246. doi: 10.2165/00003088-200544120-00003.", "ArticleIdList": ["10.2165/00003088-200544120-00003", "16372822"]}, {"Citation": "Tagalakis V., Blostein M., Robinson-Cohen C., Kahn S. R. The effect of anticoagulants on cancer risk and survival: systematic review. Cancer Treatment Reviews. 2007;33:358\u2013368.", "ArticleIdList": ["17408861"]}, {"Citation": "Stefanachi A., Leonetti F., Pisani L., Catto M., Carotti A. Coumarin: a natural, privileged and versatile scaffold for bioactive compounds. Molecules. 2018;23(2):p. 250.", "ArticleIdList": ["PMC6017103", "29382051"]}, {"Citation": "Guillon C., Jan Y. H., Heck D. E., et al. Phototoxicity of 7-oxycoumarins with keratinocytes in culture. Bioorganic Chemistry. 2019;89:p. 103014. doi: 10.1016/j.bioorg.2019.103014.", "ArticleIdList": ["10.1016/j.bioorg.2019.103014", "PMC6656587", "31170642"]}, {"Citation": "Iwata N., Kainuma M., Kobayashi D., et al. The relation between hepatotoxicity and the total coumarin intake from traditional Japanese medicines containing cinnamon bark. Frontiers in Pharmacology. 2016;7:174\u2013174.", "ArticleIdList": ["PMC4913087", "27378929"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "6", "Day": "30"}, {"Year": "2021", "Month": "7", "Day": "31"}, {"Year": "2021", "Month": "8", "Day": "5"}, {"Year": "2021", "Month": "9", "Day": "17", "Hour": "7", "Minute": "14"}, {"Year": "2021", "Month": "9", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["34531939", "PMC8440074", "10.1155/2021/6492346"]}}], "PubmedBookArticle": []}